Energy companies operating in the U.S. Gulf Coast have started to scale back operations and evacuate production locations in ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 ...

Let’s talk about insider trading. Not the illegal kind, but the perfectly normal – and fully legal – trading by top-level ...

The NMIBC market is gaining momentum, with ~13 therapies anticipated to enter key markets by 2034. DelveInsight projects that three critical drugs will secure billion-dollar markets across the 7MM by ...

Indian shares were set to open at record highs on Tuesday, tracking gains in Asian peers, and extending their rally after the ...

The Global Polyurethane Foam Market Size is projected to grow at a CAGR of 7.77% from 2024 to 2031, according to a new report ...

The global Animal Antibacterial and Antibiotics Market is projected to grow from approximately USD 4.9 billion in 2024 to ...

MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company ...

Professor Peter Nockemann, FRSC, is the Programme Director for the MSc in Pharmaceutical Analysis at QUB. His research focuses on Inorganic and Materials Chemistry, with a keen interest in ...

For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American Depositary ...